These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 30048054
1. The importance of serum interleukin-20 levels in patients with Behçet's disease. Enecik ME, Mavi B, Yücel Ç, Keskin G, Yıldız M. Adv Clin Exp Med; 2018 Oct; 27(10):1391-1395. PubMed ID: 30048054 [Abstract] [Full Text] [Related]
2. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease. Çerçi P, Altıner S, İnal A, Köse K, Keskin G, Ölmez Ü. Acta Clin Belg; 2017 Dec; 72(6):434-438. PubMed ID: 28412856 [Abstract] [Full Text] [Related]
3. Increased serum interleukin-32 levels in patients with Behçet's disease. Ha YJ, Park JS, Kang MI, Lee SK, Park YB, Lee SW. Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461 [Abstract] [Full Text] [Related]
4. Serum IL-33 levels and skin mRNA expression in Behçet's disease. Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj-Sassi F. Clin Exp Rheumatol; 2013 Dec; 31(3 Suppl 77):6-14. PubMed ID: 23464866 [Abstract] [Full Text] [Related]
5. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease. Balkarli A, Kucuk A, Babur H, Erbasan F. Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3045-50. PubMed ID: 27460734 [Abstract] [Full Text] [Related]
6. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients. Sonmez C, Yucel AA, Yesil TH, Kucuk H, Sezgin B, Mercan R, Yucel AE, Demirel GY. Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072 [Abstract] [Full Text] [Related]
7. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A. Clin Exp Rheumatol; 2007 Oct; 25(4 Suppl 45):S70-5. PubMed ID: 17949555 [Abstract] [Full Text] [Related]
8. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement. Durmazlar SP, Ulkar GB, Eskioglu F, Tatlican S, Mert A, Akgul A. Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013 [Abstract] [Full Text] [Related]
9. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease? Keskin D, Keskin G, Inal A, Ozışık L. Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748 [Abstract] [Full Text] [Related]
10. Increased advanced oxidation protein products in Behçet's disease: a new activity marker? Yazici C, Köse K, Caliş M, DemIr M, Kirnap M, Ateş F. Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878 [Abstract] [Full Text] [Related]
11. Lack of association between serum IL-9 levels and Behçet's disease. Nouri-Vaskeh M, Malek Mahdavi A, Khabbazi A, Jadideslam G. Immunol Lett; 2019 Jul; 211():23-27. PubMed ID: 31095970 [Abstract] [Full Text] [Related]
12. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease. Aridogan BC, Yildirim M, Baysal V, Inaloz HS, Baz K, Kaya S. J Dermatol; 2003 Aug; 30(8):602-7. PubMed ID: 12928529 [Abstract] [Full Text] [Related]
13. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study. Duygulu F, Evereklioglu C, Calis M, Borlu M, Cekmen M, Ascioglu O. Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528 [Abstract] [Full Text] [Related]
14. Levels of soluble E-selectin in patients with active Behcet's disease. Sari RA, Kiziltunç A, Taysi S, Akdemir S, Gündoğdu M. Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451 [Abstract] [Full Text] [Related]
15. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease. Adam B, Calikoglu E. J Eur Acad Dermatol Venereol; 2004 May; 18(3):318-20. PubMed ID: 15096143 [Abstract] [Full Text] [Related]
16. IL-38 serum levels in patients with Behcet's disease and the relationship with clinical features. Zarrabi M, Gholijani N, Shenavandeh S, Aflaki E, Amirghofran Z. Eur Cytokine Netw; 2019 Sep 01; 30(3):82-87. PubMed ID: 31957702 [Abstract] [Full Text] [Related]
17. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations. Fawzy RM, Said EA, Mohamed SM, Fouad NA, Akl EM. Egypt J Immunol; 2015 Jun 01; 22(2):1-8. PubMed ID: 28502139 [Abstract] [Full Text] [Related]
18. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet's disease. Şahin E, Karaman G, Uslu M, Karul A, Şendur N, Şavk E. J Eur Acad Dermatol Venereol; 2012 Dec 01; 26(12):1498-502. PubMed ID: 22035239 [Abstract] [Full Text] [Related]
19. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis? Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A. Rheumatol Int; 2006 May 01; 26(7):608-13. PubMed ID: 16205926 [Abstract] [Full Text] [Related]
20. Serum IL-4, IL-12, IL-13, IL-27, and IL-33 levels in active and inactive ocular Behcet's disease. Cingu AK, Turkcu FM, Aktas S, Sahin A, Ayyildiz O. Int Ophthalmol; 2020 Dec 01; 40(12):3441-3451. PubMed ID: 32729061 [Abstract] [Full Text] [Related] Page: [Next] [New Search]